Smith Christopher Charles 4

What Happened

• Christopher Charles Smith, a director of Park Dental Partners, was granted 2,632 restricted stock units (RSUs) on 2026-06-15. The grant is reported as an award/acquisition (code A) with an acquisition price of $0.00 (derivative), so there was no cash paid by the insider.

Key Details

• Transaction date: 2026-06-15; Form 4 filed: 2026-06-22.
• Security: Restricted Stock Units (each RSU = contingent right to one share) — 2,632 RSUs granted.
• Price reported: $0.00 per unit; total reported acquisition value: $0 (award/derivative).
• Vesting: RSUs vest in full on the first anniversary of the grant (per footnote), subject to continued service as a director and award terms.
• Footnotes: F1 = each RSU converts to one share upon vesting; F2 = full vesting on first anniversary conditional on service; F3 = granted for no cash consideration.
• Shares owned after transaction: not specified in the filing.
• Timeliness: The Form 4 was filed seven days after the transaction date (filed 2026-06-22 for a 2026-06-15 grant), which appears later than the typical two-business-day filing requirement for insiders.

Context

• This was a compensation award (RSUs), not a market purchase or sale. RSU grants are common director compensation and do not represent immediately tradable shares until they vest. The filing shows no cash outlay by the insider and no immediate liquidity event.